Commitments and Contingencies - Additional Information (Details) - USD ($)	1 Months Ended		12 Months Ended
	Jun. 30, 2022	Jan. 31, 2021	Dec. 31, 2024	Dec. 31, 2023
Lilly Agreement
Loss Contingencies [Line Items]
Upfront payment		$ 5,000,000
Royalties incurred			$ 0
Lilly Agreement | Maximum
Loss Contingencies [Line Items]
Tiered percentage royalty on annual net sales		10.00%
Akoya Agreement
Loss Contingencies [Line Items]
Upfront payment	$ 600,000
Obligation to pay upon achievement of specified development milestones	$ 20,300,000
Milestone payments			14,600,000
Akoya Agreement | Accrued Expenses and Other Current Liabilities
Loss Contingencies [Line Items]
Milestones due amounts			2,500,000
Research and Development Expense | Akoya Agreement
Loss Contingencies [Line Items]
Milestones expenses			$ 8,800,000	$ 6,000,000
Development and Commercial Milestone | Lilly Agreement
Loss Contingencies [Line Items]
Milestone payments		$ 168,000,000